Diving medical 550 million acquisition of 38.38% of the excellent medicine | Shares | to achieve full control

Medical network January 26 hearing 'From the acquisition of medical supplies in Suzhou in Suzhou in the beginning, diving medical seems to find medical supplies in the field of' New World ', after continued acquisitions, the product line has become a scale, the action from the 2017 point of view, Clinical medical business has become a key cultivation sector.

Shangyou Group and Zhongyou Medicine are the leading elites in their respective sub-channels with strong channel resources and strong synergies. After achieving a wholly-owned shareholding, diving medical care is more handy in resource allocation.

Yesterday, Di Yu medical announcement, announced on January 23 signed the "Shanghai Zhongyou Pharmaceutical Hi-Tech Co., Ltd. shares transfer letter of intent," intended to acquire Bian Xuelian held Shanghai Zhongyou Pharmaceutical High-tech Co., Ltd. 38.3775% of the shares, the two parties initially agreed to the subject of the shares of the company does not exceed 550 million yuan transfer price, using cash payments.

Data show that the business activities of the best medicine, including medicine, cosmetic Technology development; two types of medical equipment, disinfectants, health products sales, etc. It is worth mentioning that the excellent medicine The disinfection industry business at different levels at home and abroad hospital There has been a better brand of precipitation, especially in the field of hand and skin disinfection, 'Jiefu Rou', 'Aner iodine' and other well-known brands in the hospital foundation solid.

Previously, Zhongyou Pharmaceutical had two major shareholders, of which Yu Yue Healthcare held 61,622,500 shares, accounting for 61.62%; Yan Xuelian held 3,837,750 shares, accounting for 38.38%.

Upon the completion of the acquisition, Zhongyou Pharma will become a wholly-owned subsidiary of Yuyue Medical, directly or indirectly.

For this acquisition, Yuyue Medical stated that it is based on optimistic about the development of infectious disease prevention and control and infection control industries, and that Zhongyou Medical Disinfection has great advantages in home care and disinfection. The wholly-owned holding company Zhongyou Medicine is beneficial to Yueyue Medical. Its resource optimization configuration.

After the two parties signed a formal agreement, Di Yu Medical will consolidate 100% of the shares of Zhongyou Pharmaceutical. With the synergies between the two parties in terms of channels and resources, it will actively promote the profitability, performance growth and industry status of Di Yu Medical effect.

In 2014, Di Yu Medical completed the acquisition of 100% of Shangli Group and 51.51% equity of Huarun Wandong and injected Shangli Group into the listed company to divest the medical imaging business to Huarun Wandong. The integrated diving medical service will be used for household use medical instruments And high-value medical supplies for strategic development.

In the home medical equipment, diving medical channels have obvious advantages, complete variety layout.

Medical high-value supplies, diving medical aggressive mergers and acquisitions over the past few years, the hospital product line has also gradually become the scale of the most important time in 2009 to 310 million acquisition of Suzhou Medical Supplies Factory, strategic into medical supplies field.

In 2016, Di Yu Medical, at a premium of over 400%, acquired a 61.6225% stake in Zhongyou Medicine for a consideration of RMB860 million in order to provide surgical instruments and disinfection services to hospitals. As a starting point, it managed to expand the hospital's supply outsourcing business through intervention in hospital supply chain management .

In addition, the disinfection business of Zhongyou Pharma can not only effectively integrate with the surgical instrument plate of Shangli Group, a subsidiary of listed company, and further enhance the competitiveness of the surgical instrument plate, but also exploit the OTC force of diving medical treatment to open up markets and enrich its Business in the beautiful life sector.

By 2017, Diving Medical has significantly accelerated its pace of "buying and buying." According to incomplete statistics from the New Horizon, in 2017, Diving Medical acquired 4 enterprise Stake in the launch, subscribe for two medical industry mergers and acquisitions fund.

In February, Diving Medical acquired Metrax, a maker of defibrillators, through the acquisition of Yuwell Germany GmbH, a German-based subsidiary, to bring down the world's leading brand,

In May, Diving Medical joined Amsino Medical, whose core product is a disposable medical device with infection control, antibacterial coating and safety-free needle as the core technology;

In November, Di Yu medical wholly-owned subsidiary of Shanghai Pharmaceutical Group to 500 million acquisition of Orthopedics 100% stake;

In December, Wadong Medical, a subsidiary of Di Yu Medical, announced that it had acquired Yum! Medical for 248 million euros (about RMB 1.377 billion yuan). (For more details, please mark "Ma Yun, Wu Guangming and Yu Rong jointly acquire what Yum! ? ")

In May, with its own funds invested 20 million yuan, to participate in the subscription Huaguo Pa Hsin-cheng medical and health investment in Chengdu partnership initiated by the medical industry fund;

In November, YuDui Technology set up a joint venture with Jiangsu Yuquan Zhongwei Tengyun Medical and Health Industry Investment Fund, of which Yuyue Medical invested 100 million yuan, accounting for 12.5% ​​of the fund's share. The investment directions include medicine and health and its related Big data, internet, new technology and so on.